MRVI
Maravai Lifesciences Holdings Inc
7.40$
-5.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.9% | -13.4% | +14.4% | -11.2% | -13.5% | -16.9% | +1.2% | -12.2% | +19.8% | +32.0% | -21.9% | – | |
| – | -4.3% | +9.2% | -0.2% | -3.8% | +1.7% | +4.5% | +1.3% | -9.2% | +4.6% | -14.6% | -4.2% | – | |
| – | +29.3% | -33.8% | +35.9% | -19.2% | -33.2% | -59.3% | +0.6% | -27.2% | +116.5% | +175.3% | -38.7% | – | |
| – | +5.7% | +9.5% | +5.0% | -17.8% | +5.0% | +7.2% | -0.1% | +100.1% | -61.2% | +2.7% | -4.8% | – | |
| – | -1.0% | +6.3% | -0.8% | -3.6% | +5.5% | -4.1% | -2.5% | -8.2% | -10.8% | -7.9% | +10.2% | – | |
| – | +1.3% | -3.2% | -0.1% | +342.4% | -71.1% | -0.4% | +30.2% | -248.3% | – | +64.5% | +14.4% | – | |
| – | – | – | – | – | – | – | – | – | -105.8% | – | -709.9% | – | |
| – | +32.3% | -29.5% | +9.9% | +14.2% | -17.4% | -39.8% | +0.5% | +0.4% | -4.2% | -12.3% | -16.4% | – | |
| – | – | -103.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | -998.5% | – | -102.3% | – | -2,746.9% | – | – | -2,616.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16,316.5% | -99.7% | +332.9% | -1,648.0% | – | – | – | – | – | – | -142.7% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.